Literature DB >> 24664551

Is there a relationship between the number of lymph nodes and disease parameters in patients who underwent retropubic prostatectomy.

Aslan Demir1, Mert Ali Karadağ, Levent Türkeri.   

Abstract

PURPOSE: We aimed to establish the relationship between lymph nodes (LNs) counts that were removed with standard pelvic lymph node dissection (sPLND) and different disease parameters in patients who underwent radical prostatectomy (RP).
MATERIALS AND METHODS: A total of 70 patients who underwent sPLND during RP were scanned retrospectively. The scanned parameters were levels of serum PSA, the total weight of the removed prostate, the amount as a percentage of the tumor in the prostate tissue, the stage of the tumor, the total Gleason score (GS) and the number of standard pelvic lymph nodes that were removed from both right and left sides.
RESULTS: The average age of the patients was 59 years. A positive correlation was found between the total GS and the number of lymph nodes; while this correlation was significant (p = 0.0038), there was no significant difference between lymph nodes counts and other scanned parameters. The average pelvic lymph node numbers of patients with GS of 6-7 and 8 were 10.4-11.5 and 13.2, respectively. Lymph nodes metastases were found in 3 (4.2 %) patients whose average pelvic lymph node number was 17.3.
CONCLUSION: The chance of cure or decreased recurrence is much more possible in patients who had received extended PLND or at least standard one, because of the removal of much more lymph node tissues that have a high probability of disseminating cancer cells. This position can especially be considered in patients with high GS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664551     DOI: 10.1007/s11255-014-0692-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  26 in total

1.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Authors:  Pia Bader; Fiona C Burkhard; Regula Markwalder; Urs E Studer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

2.  Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.

Authors:  Alberto Briganti; Felix K-H Chun; Andrea Salonia; Giuseppe Zanni; Vincenzo Scattoni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2006-02-17       Impact factor: 20.096

3.  Radiocolloid scintigraphic mapping of the lymphatic drainage of the prostate.

Authors:  W F Whitmore; R D Blute; W D Kaplan; R F Gittes
Journal:  J Urol       Date:  1980-07       Impact factor: 7.450

4.  Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic.

Authors:  K Weingärtner; A Ramaswamy; A Bittinger; E W Gerharz; D Vöge; H Riedmiller
Journal:  J Urol       Date:  1996-12       Impact factor: 7.450

5.  Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases.

Authors:  A P McLaughlin; S L Saltzstein; D L McCullough; R F Gittes
Journal:  J Urol       Date:  1976-01       Impact factor: 7.450

Review 6.  Lymph node assessment and lymphadenectomy in prostate cancer.

Authors:  Michael Ordon; Robert K Nam
Journal:  J Surg Oncol       Date:  2009-03-15       Impact factor: 3.454

7.  Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.

Authors:  Karim Touijer; Farhang Rabbani; Javier Romero Otero; Fernando P Secin; James A Eastham; Peter T Scardino; Bertrand Guillonneau
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

8.  Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy.

Authors:  Fernando P Secin; Thomas Jiborn; Anders S Bjartell; Georges Fournier; Laurent Salomon; Clément Claude Abbou; George P Haber; Inderbir S Gill; Laura E Crocitto; Rebecca A Nelson; José R Cansino Alcaide; Luis Martínez-Piñeiro; Michael S Cohen; Ingolf Tuerk; Claude Schulman; Troy Gianduzzo; Christopher Eden; Roxelyn Baumgartner; Joseph A Smith; Kim Entezari; Roland van Velthoven; Gunter Janetschek; Angel M Serio; Andrew J Vickers; Karim Touijer; Bertrand Guillonneau
Journal:  Eur Urol       Date:  2007-06-11       Impact factor: 20.096

Review 9.  Lymphatic drainage and CTV in carcinoma of the prostate.

Authors:  Numa Cellini; Stefano Luzi; Giovanna Mantini; Gian Carlo Mattiucci; Alessio G Morganti; Cinzia Digesù; Antonella Bavasso; Francesco Deodato; Daniela Smaniotto; Vincenzo Valentini
Journal:  Rays       Date:  2003 Jul-Sep

10.  Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

Authors:  D L Bluestein; D G Bostwick; E J Bergstralh; J E Oesterling
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.